Cargando…
Association of Over-Expressed Estrogen Receptor Alpha with Development of Tamoxifen Resistant Hyperplasia and Adenocarcinomas in Genetically Engineered Mice
BACKGROUND: Estrogen receptor alpha (ERα) and cyclin D1 are frequently co-expressed in human breast cancer. Some, but not all, studies link tamoxifen resistance to co-expression of cyclin D1 and ERα. In mice over-expression of either cyclin D1 or ERα in mammary epithelial cells is sufficient to indu...
Autores principales: | Miermont, Anne M, Cabrera, Marina Carla, Frech, Silvina M, Nakles, Rebecca E, Diaz-Cruz, Edgar S., Shiffert, Maddalena Tilli, Furth, Priscilla A |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3932557/ https://www.ncbi.nlm.nih.gov/pubmed/24575359 |
Ejemplares similares
-
Signal transducer and activator of transcription 5 as a key signaling pathway in normal mammary gland developmental biology and breast cancer
por: Furth, Priscilla A, et al.
Publicado: (2011) -
Conditional mouse models demonstrate oncogene-dependent differences in tumor maintenance and recurrence
por: Tilli, Maddalena T, et al.
Publicado: (2003) -
Estrogen receptor alpha in the brain mediates tamoxifen-induced changes in physiology in mice
por: Zhang, Zhi, et al.
Publicado: (2021) -
Characterization of primary mammary epithelial cells with loss of BRCA1 at a single cell level
por: Nakles, Rebecca E, et al.
Publicado: (2013) -
FOXC1 is associated with estrogen receptor alpha and affects sensitivity of tamoxifen treatment in breast cancer
por: Wang, Jinhua, et al.
Publicado: (2016)